valproic acid has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 2 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Excerpt | Relevance | Reference |
---|---|---|
" We identified a patient with a positive family history for episodic ataxia, who was originally diagnosed with epilepsy and treated with valproic acid." | 3.73 | CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. ( Bulman, DE; Friedman, JH; Scoggan, KA, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scoggan, KA | 1 |
Friedman, JH | 1 |
Bulman, DE | 1 |
Kanai, K | 1 |
Sakakibara, R | 1 |
Uchiyama, T | 1 |
Liu, Z | 1 |
Yamamoto, T | 1 |
Ito, T | 1 |
Hirano, S | 1 |
Asahina, M | 1 |
Kuwabara, S | 1 |
Hattori, T | 1 |
Fukami, G | 1 |
Arai, K | 1 |
Yamaguchi, C | 1 |
Nomura, F | 1 |
2 other studies available for valproic acid and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid.
Topics: Acetazolamide; Adult; Amino Acid Sequence; Animals; Anticonvulsants; Calcium Channels; Diagnosis, Di | 2006 |
Sporadic case of spinocerebellar ataxia type 17: treatment observations for managing urinary and psychotic symptoms.
Topics: Anticonvulsants; Electromyography; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Psychotic | 2007 |